These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14641790)

  • 1. Use of a telemetry system to examine recovery of the cardiovascular system after excitement induced by handling stress in a conscious cynomolgus monkey (Macaca fascicularis).
    Hassimoto M; Harada T
    J Med Primatol; 2003 Dec; 32(6):346-52. PubMed ID: 14641790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.
    Derakhchan K; Chui RW; Stevens D; Gu W; Vargas HM
    Br J Pharmacol; 2014 Jan; 171(2):509-22. PubMed ID: 24372552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs.
    Cordes JS; Heyen JR; Volberg ML; Poy N; Kreuser S; Shoieb AM; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2016; 79():72-9. PubMed ID: 26844408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
    Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
    J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
    Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M
    J Pharmacol Toxicol Methods; 2015; 75():44-51. PubMed ID: 25979821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 1: Non-pharmacological validation.
    Authier S; Tanguay JF; Gauvin D; Di Fruscia R; Fournier S; Chaurand F; Troncy E
    J Pharmacol Toxicol Methods; 2007; 56(2):115-21. PubMed ID: 17587601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs.
    Champeroux P; Martel E; Jude S; Laigot C; Laveissière A; Weyn-Marotte AA; Fowler JS; Maurin A; Richard S; Babuty D
    J Pharmacol Toxicol Methods; 2013; 68(1):166-74. PubMed ID: 23435316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
    Bass AS; Hanson LA; Jackson TA
    J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telemetric assessment of social and single housing: Evaluation of electrocardiographic intervals in jacketed cynomolgus monkeys.
    Kaiser RA; Tichenor SD; Regalia DE; York K; Holzgrefe HH
    J Pharmacol Toxicol Methods; 2015; 75():38-43. PubMed ID: 25959881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation.
    Authier S; Tanguay JF; Gauvin D; Fruscia RD; Troncy E
    J Pharmacol Toxicol Methods; 2007; 56(2):122-30. PubMed ID: 17587605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety assessments in the cynomolgus monkey: Unmasking potential background arrhythmias in general toxicity studies.
    Greiter-Wilke A; Baird T; O'Donohue K; Koerner A
    J Pharmacol Toxicol Methods; 2016; 81():144-50. PubMed ID: 26957141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the PhysioTel™ Digital M11 cardiovascular telemetry implant in socially housed cynomolgus monkeys up to 16weeks after surgery.
    Andersen NK; Meyer O; Bradley A; Dragsted N; Lassen AB; Sjögren I; Larsen JM; Harvey W; Bator R; Milne A
    J Pharmacol Toxicol Methods; 2017 Sep; 87():82-92. PubMed ID: 28416413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term blood glucose monitoring with implanted telemetry device in conscious and stress-free cynomolgus monkeys.
    Wang B; Sun G; Qiao W; Liu Y; Qiao J; Ye W; Wang H; Wang X; Lindquist R; Wang Y; Xiao YF
    J Endocrinol Invest; 2017 Sep; 40(9):967-977. PubMed ID: 28365864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.
    Lynch JJ; Wilson AW; Hernandez LE; Nelson RA; Marsh KC; Cox BF; Mittelstadt SW
    Br J Pharmacol; 2008 Aug; 154(7):1439-45. PubMed ID: 18516073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of electrocardiograms recorded in cynomolgus monkeys with short- and long-term intracardiac lead implantations.
    Yao JA; Feldman HS; Illenberger A; Littell T; Schnee L; Yates D
    J Pharmacol Toxicol Methods; 2009; 60(2):185-92. PubMed ID: 19523527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated cardiovascular and neurobehavioural functional assessment in the conscious telemetered cynomolgus monkey.
    Moscardo E; McPhie G; Fasdelli N; Giarola A; Tontodonati M; Dorigatti R; Meecham K
    J Pharmacol Toxicol Methods; 2010; 62(2):95-106. PubMed ID: 20601019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference intervals and method sensitivity for electrocardiology, hemodynamics, and body temperature parameters in healthy cynomolgus monkeys.
    Fang X; Tichenor SD
    J Pharmacol Toxicol Methods; 2023; 120():107247. PubMed ID: 36581147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551.
    Fleury A; Lavé T; Jonsson F; Schmitt M; Hirkaler G; Polonchuk L; Breidenbach A
    J Pharmacol Toxicol Methods; 2011; 63(1):123-33. PubMed ID: 20732434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of hyper- and hypotension during repeated dose toxicity studies in either freely moving or physically restrained cynomolgus monkeys.
    Niehoff MO; Niggemann B; Sternberg J; Jenkins A; Holbrook M
    J Pharmacol Toxicol Methods; 2014; 70(3):268-75. PubMed ID: 25219539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.